BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31025879)

  • 1. Inhibition of SKP2 Activity Impaired ATM-Mediated DNA Repair and Enhanced Sensitivity of Cisplatin-Resistant Mantle Cell Lymphoma Cells.
    Yan W; Yang Y; Yang W
    Cancer Biother Radiopharm; 2019 Sep; 34(7):451-458. PubMed ID: 31025879
    [No Abstract]   [Full Text] [Related]  

  • 2. Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma.
    Sarkar A; Stellrecht CM; Vangapandu HV; Ayres M; Kaipparettu BA; Park JH; Balakrishnan K; Burks JK; Pandita TK; Hittelman WN; Neelapu SS; Gandhi V
    Haematologica; 2021 Feb; 106(2):495-512. PubMed ID: 32029507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhou ZY; Yang JY; Shao CZ; Luo F; Du W
    World J Surg Oncol; 2022 Mar; 20(1):88. PubMed ID: 35303867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
    Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
    J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma.
    Liu Z; Liu J; Zhang T; Li L; Zhang S; Jia H; Xia Y; Shi M; Zhang J; Yue S; Chen X; Yu J
    BMC Cancer; 2021 Jun; 21(1):732. PubMed ID: 34174847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
    Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
    Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.
    Knapp CM; He J; Lister J; Whitehead KA
    Exp Biol Med (Maywood); 2016 May; 241(9):1007-13. PubMed ID: 27022142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.
    Menezes DL; Holt J; Tang Y; Feng J; Barsanti P; Pan Y; Ghoddusi M; Zhang W; Thomas G; Holash J; Lees E; Taricani L
    Mol Cancer Res; 2015 Jan; 13(1):120-9. PubMed ID: 25232030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.
    Ben Younes K; Body S; Costé É; Viailly PJ; Miloudi H; Coudre C; Jardin F; Ben Aissa-Fennira F; Sola B
    BMC Cancer; 2017 Aug; 17(1):538. PubMed ID: 28797244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.
    Restelli V; Chilà R; Lupi M; Rinaldi A; Kwee I; Bertoni F; Damia G; Carrassa L
    Oncotarget; 2015 Nov; 6(35):37229-40. PubMed ID: 26439697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P; Li J; Jiang HG; Lan T; Chen YC
    Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.
    Li D; Ye L; Lei Y; Wan J; Chen H
    BMB Rep; 2019 Mar; 52(3):208-213. PubMed ID: 30638177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suppression of ATR reverses the cisplatin resistance in ovarian cancer SKOV3 cells].
    Yang Z; Sun C; Liu Y; Gong C; Chen G; Weng D
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):805-10. PubMed ID: 25620475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway.
    Zhang Y; Lu P; Zhou Y; Zhang L
    PeerJ; 2021; 9():e12571. PubMed ID: 35003920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines.
    Mohanty S; Mohanty A; Sandoval N; Tran T; Bedell V; Wu J; Scuto A; Murata-Collins J; Weisenburger DD; Ngo VN
    Leuk Lymphoma; 2017 Mar; 58(3):676-688. PubMed ID: 27338091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
    Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
    M'kacher R; Bennaceur A; Farace F; Laugé A; Plassa LF; Wittmer E; Dossou J; Violot D; Deutsch E; Bourhis J; Stoppa-Lyonnet D; Ribrag V; Carde P; Parmentier C; Bernheim A; Turhan AG
    Oncogene; 2003 Sep; 22(39):7905-12. PubMed ID: 12970738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.
    Yu X; Wang R; Zhang Y; Zhou L; Wang W; Liu H; Li W
    Oncogene; 2019 Dec; 38(50):7457-7472. PubMed ID: 31435020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma.
    Ahmed M; Li L; Pinnix C; Dabaja B; Nomie K; Lam L; Wang M
    Crit Rev Oncol Hematol; 2016 Nov; 107():14-19. PubMed ID: 27823642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.